Skip to main content
ObGyn
ALL Specialities
ALL Specialities
/
ObGyn
CME
Conference Coverage
COVID-19 Updates
Diseases and Conditions
Abnormal Uterine Bleeding
Breast Cancer
Contraception
Endometriosis
Female Sexual Dysfunction
Gynecologic Cancer
Long COVID
Menopause
Osteoporosis
Pelvic Floor Dysfunction
Preterm Birth
Preventive Care
Specialties
Gynecology
Obstetrics
Reproductive Endocrinology
Surgery
Hysterectomy
Myomectomy
Transgender Health
OBG Management
Current and Past Issues
Conference Coverage
Expert: Don’t discourage pregnancy in MS patients; manage it
Publish date:
June 2, 2015
EXPERT ANALYSIS AT THE CMSC ANNUAL MEETING
dbrunk@frontlinemedcom.com
On Twitter
@dougbrunk
Pages
« first
1
2
3
Recommended Reading
FDA Approves Oral MS Drug Teriflunomide
MDedge ObGyn
Analysis: Healthy babies born after accelerated elimination of teriflunomide
MDedge ObGyn
iPad app could change how MS is measured, treated
MDedge ObGyn
FDA issues new pregnancy/lactation drug label standards
MDedge ObGyn
Botox treatments improve urinary incontinence in neurogenic bladder dysfunction
MDedge ObGyn
Obstetrics
All Specialties
MDedge Home
Cardiology
Clinician Reviews
Dermatology
Emergency Medicine
Endocrinology/Diabetes
Family Medicine
Federal Practitioner
Gastroenterology
Hematology/Oncology
Infectious Disease
Internal Medicine
Neurology
Obstetrics And Gynecology
Pediatrics
Psychiatry
Pulmonology
Rheumatology
Surgery
MDedge Home
Cardiology
Clinician Reviews
Dermatology
Emergency Medicine
Endocrinology/Diabetes
Family Medicine
Federal Practitioner
Gastroenterology
Hematology/Oncology
Infectious Disease
Internal Medicine
Neurology
Obstetrics And Gynecology
Pediatrics
Psychiatry
Pulmonology
Rheumatology
Surgery